Novo Nordisk A/S (BKK:NOVOB80)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of THB 6.85 trillion. The enterprise value is 7.36 trillion.

Market Cap	6.85T
Enterprise Value	7.36T

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Aug 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.34%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	28.07%
Float	3.19B

Valuation Ratios

The trailing PE ratio is 13.48 and the forward PE ratio is 14.75.

PE Ratio	13.48
Forward PE	14.75
PS Ratio	4.47
PB Ratio	7.12
P/TBV Ratio	21.58
P/FCF Ratio	23.42
P/OCF Ratio	11.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.59, with an EV/FCF ratio of 25.18.

EV / Earnings	14.50
EV / Sales	4.81
EV / EBITDA	9.59
EV / EBIT	10.57
EV / FCF	25.18

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.67.

Current Ratio	0.80
Quick Ratio	0.54
Debt / Equity	0.67
Debt / EBITDA	0.85
Debt / FCF	2.22
Interest Coverage	33.42

Financial Efficiency

Return on equity (ROE) is 60.70% and return on invested capital (ROIC) is 41.13%.

Return on Equity (ROE)	60.70%
Return on Assets (ROA)	17.43%
Return on Invested Capital (ROIC)	41.13%
Return on Capital Employed (ROCE)	42.97%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	22.16M
Profits Per Employee	7.34M
Employee Count	69,505
Asset Turnover	0.61
Inventory Turnover	1.20

Taxes

In the past 12 months, Novo Nordisk has paid 139.35 billion in taxes.

Income Tax	139.35B
Effective Tax Rate	21.53%

Stock Price Statistics

The stock price has decreased by -47.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-47.67%
50-Day Moving Average	1.69
200-Day Moving Average	1.92
Relative Strength Index (RSI)	38.97
Average Volume (20 Days)	12,501,058

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of THB 1.53 trillion and earned 507.86 billion in profits. Earnings per share was 114.18.

Revenue	1.53T
Gross Profit	1.26T
Operating Income	697.18B
Pretax Income	647.21B
Net Income	507.86B
EBITDA	760.03B
EBIT	697.18B
Earnings Per Share (EPS)	114.18

Balance Sheet

The company has 133.68 billion in cash and 649.28 billion in debt, with a net cash position of -515.61 billion.

Cash & Cash Equivalents	133.68B
Total Debt	649.28B
Net Cash	-515.61B
Net Cash Per Share	n/a
Equity (Book Value)	962.08B
Book Value Per Share	216.49
Working Capital	-214.22B

Cash Flow

In the last 12 months, operating cash flow was 590.50 billion and capital expenditures -298.17 billion, giving a free cash flow of 292.33 billion.

Operating Cash Flow	590.50B
Capital Expenditures	-298.17B
Free Cash Flow	292.33B
FCF Per Share	n/a

Margins

Gross margin is 82.41%, with operating and profit margins of 45.50% and 33.14%.

Gross Margin	82.41%
Operating Margin	45.50%
Pretax Margin	42.24%
Profit Margin	33.14%
EBITDA Margin	49.60%
EBIT Margin	45.50%
FCF Margin	19.08%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 2.62%.

Dividend Per Share	0.04
Dividend Yield	2.62%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	50.53%
Buyback Yield	0.34%
Shareholder Yield	2.96%
Earnings Yield	7.42%
FCF Yield	4.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novo Nordisk has an Altman Z-Score of 5.15 and a Piotroski F-Score of 5.

Altman Z-Score	5.15
Piotroski F-Score	5